STAG2 - a gene commonly mutated in several human cancers that plays an essential role in DNA replication, revealing potential mechanisms for therapeutically targeting glioblastoma and other cancers has been discovered by UCSF researchers.
As part of a multi-protein complex called cohesin, the STAG2 protein has been implicated in numerous cellular functions. The cohesin complex, which forms a ring-like structure that encircles DNA molecules, was first identified for its role in regulating the separation of DNA chromatids during mitosis (the process of cell division).
Glioblastoma Multiforme
Glioblastomas are tumors that arise from astrocytes that make up the supportive tissue of the brain. Glioblastomas are usually highly malignant.
Advertisement
‘STAG2 inactivation is often associated with TP53 mutations, and in some cancers such as Ewing sarcoma, the combination of these mutations is associated with worse prognosis. ’
Tweet it Now
Published today in Nature Communications,1 UCSF neuropathologist and cancer biologist David Solomon, MD, PhD and colleagues identify a new role for STAG2. "We found that STAG2 is required for replication fork progression, which can be exploited as a therapeutic vulnerability in STAG2-mutant cancers," said Solomon.
The replication fork is a structure that forms when DNA molecules are being replicated. Each strand of the DNA double helix is unwound and becomes a template for a new, matching partner strand, which is built and extended as the replication fork progresses.
![Glioblastoma Vaccine Shows Encouraging Results in Phase Ib Clinical Trial]( "Glioblastoma Vaccine Shows Encouraging Results in Phase Ib Clinical Trial")
New brain-cancer vaccine which was under investigation for more than 20 years suspends cancer growth in enrolled patients in clinical trial.
The Solomon Lab reports that loss of STAG2, in normal cells, causes the replication fork to stall by disrupting interactions between the cohesin complex and DNA replication proteins. This leads to replication fork collapse and causes double-strand breaks in the DNA; consequent activation of DNA damage signaling pathways ultimately halts the cell cycle, thus preventing cell proliferation.
This leads to replication fork collapse and causes double-strand breaks in the DNA; consequent activation of DNA damage signaling pathways ultimately halts the cell cycle, thus preventing cell proliferation.
However, STAG2 inactivation behaves differently in tumor cells.
Source: Newswise
Glioblastoma Vaccine Shows Encouraging Results in Phase Ib Clinical Trial
New brain-cancer vaccine which was under investigation for more than 20 years suspends cancer growth in enrolled patients in clinical trial.
Advertisement
The Solomon Lab reports that loss of STAG2, in normal cells, causes the replication fork to stall by disrupting interactions between the cohesin complex and DNA replication proteins. This leads to replication fork collapse and causes double-strand breaks in the DNA; consequent activation of DNA damage signaling pathways ultimately halts the cell cycle, thus preventing cell proliferation.
This leads to replication fork collapse and causes double-strand breaks in the DNA; consequent activation of DNA damage signaling pathways ultimately halts the cell cycle, thus preventing cell proliferation.
However, STAG2 inactivation behaves differently in tumor cells.
Source: Newswise
Quiz on Cancer
Cancer, is the second most leading cause of death worldwide. Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Take this quiz on and test how much you know about cancer.
Advertisement
 Lifetime Risk Calculator for CancersWhat are your chances for developing some common cancers in your lifetime - find out now. | Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.
Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.
Improved oral health, as indicated by the count of natural teeth and dental appointments preceding the diagnosis, correlated with enhanced head and neck cancer survival rates.
